Pilot study of neoadjuvant chemotherapy with S-1 and oxaliplatin clinical Stage III gastric cancer
Not Applicable
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000031388
- Lead Sponsor
- Kyoto Katsura Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) With active double or multiple cancers 2) Severe complications 3) With active infection 4) Past history of severe hypersensitivity to drugs 5) Under treatment with flucytosine 6) Under treatment with warfarin 7) Pregnant women, or women with the possibility of the pregnancy, Men who want let to pregnancy 8) Patients judged inappropriate for the study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Completion rate of neoadjuvant chemotherapy Completion rate of adjuvant chemotherapy Pathological response rate Incidence of adverse events of neoadjuvant chemotherapy Incidence of postoperative complications R0 resection rate Progression-free survival Overall survival Completion rate of laparoscopic surgery